Malignant trophoblastic neoplasms of placenta ICD11 code: 2D25.0
Parenteral > General injections > IV: 500 µg in vial powder for injection
Adolescents and adults
The recommendation is for this specific medicine
Patents have expired in most jurisdictions
Read more about patents.
Summary of evidence and Expert Committee recommendations
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, listing for dactinomycin on the complementary list of the EML for use in treatment protocols for gestational trophoblastic neoplasia was specifically endorsed. The relevant extracts from TRS994 regarding the Expert Committee's 2015 consideration of treatment protocols for gestational trophoblastic neoplasia is attached.